Jun 10, 2020 / 12:50PM GMT
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
We are at the 8:50 a.m. session of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I'm the European biotech analyst for the firm, and I also cover U.S. biopharma names as well. But I've got the pleasure this morning of hosting MorphoSys, and joining us from the company today is Jean-Paul Kress, who's Chief Executive Officer of the company. So let me thank you, Jean-Paul, for joining us. But perhaps before we go into our fireside chat, obviously, let me welcome you to your first Goldman Sachs Healthcare Conference. And obviously, we look forward to your participation in many years to come.
Questions and Answers:
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research AnalystYou were named CEO about a year ago, maybe a little over a year ago. And so would like to maybe start off this fireside chat in asking you how you think the year has gone. What
Trustpilot
